Adjuvant systemic therapy in early breast cancer: impact of guideline changes and clinicopathological factors associated with nonadherence at a nation-wide level.
about
Adjuvant systemic therapy in early breast cancer: impact of guideline changes and clinicopathological factors associated with nonadherence at a nation-wide level.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Adjuvant systemic therapy in e ...... erence at a nation-wide level.
@en
Adjuvant systemic therapy in e ...... erence at a nation-wide level.
@nl
type
label
Adjuvant systemic therapy in e ...... erence at a nation-wide level.
@en
Adjuvant systemic therapy in e ...... erence at a nation-wide level.
@nl
prefLabel
Adjuvant systemic therapy in e ...... erence at a nation-wide level.
@en
Adjuvant systemic therapy in e ...... erence at a nation-wide level.
@nl
P2093
P2860
P1476
Adjuvant systemic therapy in e ...... herence at a nation-wide level
@en
P2093
A M F Verschoor
C H Van Gils
T van Dalen
P2860
P2888
P304
P356
10.1007/S10549-016-3940-7
P407
P577
2016-08-12T00:00:00Z